FALCO HOLDINGS Co., Ltd. (4671.T)
- Previous Close
2,329.00 - Open
2,333.00 - Bid 2,324.00 x --
- Ask 2,345.00 x --
- Day's Range
2,314.00 - 2,347.00 - 52 Week Range
2,053.00 - 2,539.00 - Volume
41,600 - Avg. Volume
13,750 - Market Cap (intraday)
25.028B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
14.24 - EPS (TTM)
164.66 - Earnings Date May 13, 2025
- Forward Dividend & Yield 126.00 (5.41%)
- Ex-Dividend Date Mar 28, 2025
- 1y Target Est
--
FALCO HOLDINGS Co., Ltd., a medical service company, provides clinical testing and dispensing pharmacy services to medical institutions and companies in Japan. It offers clinical testing services in the fields of genetic tests, biochemistry, hematology, pathology, immunology, and microbiology; and genetic testing services. The company also provides medical information technology services; and develops in vitro diagnostics for unmet medical needs. In addition, it is involved in the dispensing pharmacies and drugstores business; and development and sale of various medical chart systems, including HAYATE / NEO, a cloud-based electronic medical chart for small and medium-sized hospitals, as well as @home Dr., an electronic medical chart for bed less clinics. FALCO HOLDINGS Co., Ltd. was founded in 1962 and is headquartered in Osaka, Japan.
www.falco-hd.co.jp1,117
Full Time Employees
March 31
Fiscal Year Ends
Sector
Industry
Recent News: 4671.T
View MorePerformance Overview: 4671.T
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 4671.T
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 4671.T
View MoreValuation Measures
Market Cap
24.86B
Enterprise Value
15.21B
Trailing P/E
14.15
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.57
Price/Book (mrq)
0.97
Enterprise Value/Revenue
0.35
Enterprise Value/EBITDA
5.53
Financial Highlights
Profitability and Income Statement
Profit Margin
4.06%
Return on Assets (ttm)
4.00%
Return on Equity (ttm)
6.87%
Revenue (ttm)
43.42B
Net Income Avi to Common (ttm)
1.76B
Diluted EPS (ttm)
164.66
Balance Sheet and Cash Flow
Total Cash (mrq)
10.2B
Total Debt/Equity (mrq)
2.15%
Levered Free Cash Flow (ttm)
--